Vitamin D-induced ectodomain shedding of TNF receptor 1 as a nongenomic action: D3 vs D2 derivatives
- 1 January 2016
- journal article
- Published by Elsevier BV in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 155, 18-25
- https://doi.org/10.1016/j.jsbmb.2015.09.019
Abstract
No abstract availableKeywords
Funding Information
- Asan Institute for Life Sciences (Seoul, Korea) (02-200)
This publication has 38 references indexed in Scilit:
- Dose-dependent effects of vitamin D on transdifferentiation of skeletal muscle cells to adipose cellsJournal of Endocrinology, 2013
- Efficacy and Safety of Paricalcitol Therapy for Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2012
- Vitamin D Receptor (VDR) Regulation of Voltage-Gated Chloride Channels by Ligands Preferring a VDR-Alternative Pocket (VDR-AP)Molecular Endocrinology, 2011
- A molecular description of ligand binding to the two overlapping binding pockets of the nuclear vitamin D receptor (VDR): Structure-function implicationsThe Journal of Steroid Biochemistry and Molecular Biology, 2010
- An Arginine Stretch Limits ADAM10 Exit from the Endoplasmic ReticulumOnline Journal of Public Health Informatics, 2010
- A Randomized Trial of Cholecalciferol versus Doxercalciferol for Lowering Parathyroid Hormone in Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2010
- On the Mechanism Underlying (23S)-25-Dehydro-1α(OH)-vitamin D3-26,23-lactone Antagonism of hVDRwt Gene Activation and Its Switch to a SuperagonistOnline Journal of Public Health Informatics, 2009
- Changes in Serum 25-Hydroxyvitamin D and Plasma Intact PTH Levels Following Treatment With Ergocalciferol in Patients With CKDAmerican Journal of Kidney Diseases, 2007
- ParicalcitolDrugs, 2005
- Effective suppression of parathyroid hormone by 1α-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidismKidney International, 1997